By identifying these risks, the test provides insights into maintaining microbial balance, protecting the intestinal barrier, and supporting immunity
Recent studies have indicated that novel therapeutics can be created using tumor-suppressive peptides in place of existing chemotherapeutics that are ineffective at targeting metastases
High blood sugar and obesity increase both of these, which can damage brain cells and lead to problems with memory or thinking
Some of the drugs for obesity treatment in the early and late stages of development include Semaglutide oral (Novo Nordisk), Tirzepatide (Eli Lilly and Company), Tesomet (Saniona), RZL-012 (Raziel Therapeutics), EMP16 (Empros Pharma), DD01 (D&D Pharmatech), ZP 8396 (Zealand Pharma), ERX-1000 (ERX Pharmaceuticals), Survodutide (Zealand Pharma), Ecnoglutide (Sciwind Biosciences), CT-868 (Carmot Therapeutics), DD01 (D&D Pharmatech), and others